Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04648150Not ApplicableCompleted

Evaluation of a Millimeter Wave Emission Bracelet for Improving Parkinson's Disease Symptoms

Role: collaborator

NCT04568252Not ApplicableCompleted

Migraine STImulation Crisis of Migraine

Role: lead

NCT05058092Not ApplicableCompleted

Evaluation of the Effectiveness of the Remedee Solution in Fibromyalgia

Role: lead

NCT04590079Not ApplicableCompleted

Innovative Device for Pain Management by Millimeter Band Radiation : Electronic-Pain Killer.

Role: collaborator

NCT04801550Not ApplicableCompleted

Study of Somatosensory Responses During Millimeter Waves Application

Role: collaborator

NCT03889288Not ApplicableUnknown

Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer

Role: collaborator

All 6 trials loaded